tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
AstraZeneca PLC (DE:ZEG)
XETRA:ZEG
Germany Market
ZEG
AstraZeneca
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

AstraZeneca (ZEG) Stock News & Sentiment

Compare
10 Followers
Capital Group Increases Stake in AstraZeneca
Premium
Company Announcements
Capital Group Increases Stake in AstraZeneca
2h ago
AstraZeneca’s Promising Future: Buy Rating Backed by Robust Pipeline and Strong Sales Potential
Premium
Ratings
AstraZeneca’s Promising Future: Buy Rating Backed by Robust Pipeline and Strong Sales Potential
1d ago
AZN
AstraZeneca’s Promising Pipeline and Market Potential Drive Buy Rating Amid Positive Competitor Data
Premium
Ratings
AstraZeneca’s Promising Pipeline and Market Potential Drive Buy Rating Amid Positive Competitor Data
2d ago
AZN
AstraZeneca Awards Shares to CEO and CFO Under Incentive Plans
Premium
Company Announcements
AstraZeneca Awards Shares to CEO and CFO Under Incentive Plans
7d ago
AstraZeneca Announces Share Capital and Voting Rights Update
Premium
Company Announcements
AstraZeneca Announces Share Capital and Voting Rights Update
9d ago
AstraZeneca’s Growth Potential Highlighted by Positive Risk-Reward Scenario and Strategic Drug Portfolio
Premium
Ratings
AstraZeneca’s Growth Potential Highlighted by Positive Risk-Reward Scenario and Strategic Drug Portfolio
9d ago
AZN
AstraZeneca’s Imfinzi Regimen Recommended for EU Approval in Lung Cancer Treatment
Premium
Company Announcements
AstraZeneca’s Imfinzi Regimen Recommended for EU Approval in Lung Cancer Treatment
10d ago
More DE:ZEG News >

ZEG News on the Web

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe
Yahoo Finance
Neutral
AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
Pharmaceutical Technology
Neutral
AstraZeneca reports positive outcomes from trial of Imfinzi
Clinical Trials Arena
Neutral
AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients
Yahoo Finance
Neutral
IMFINZI® -based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers
Yahoo Finance
Neutral
AstraZeneca’s Imfinzi success a step towards $80bn revenue aim - analyst
Proactive Investors
Neutral
AstraZeneca's Imfinzi shows promise in early-stage stomach and oesophageal cancer
Proactive Investors
Neutral
Astrazeneca Stock Moves -0.63%: What You Should Know
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
DE:ZEG
Sector Average
Media Buzz
This Week9 articles
Weekly Average13.75 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ZEG’s Media Buzz Sentiment?
9 articles about DE:ZEG were published this week. In an average week, 13.75 articles are published.
    What is DE:ZEG’s weekly average amount of articles?
    In an average week, 13.75 articles about DE:ZEG are published.
      What is DE:ZEG’s News Sentiment?
      59% of articles about DE:ZEG were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        PTGXProtagonist Therapeutics
        FENCFennec Pharmaceuticals
        CKPTCheckpoint Therapeutics
        CSBTFKuros Biosciences
        MDPediatrix Medical Group
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing